Regulation of B-cell fate by antigen-receptor signals

Nature Reviews Immunology

Volumn 2, Issue 12, 2002, Pages 945-956

  Niiro, Hiroaki ^a   Clark, Edward A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE C; RAF PROTEIN; RAS PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; APOPTOSIS; B LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ANTIBODY PRODUCTION; CELL DIVISION; CELL MEMBRANE; CYTOLOGY; GENE DELETION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOPOIESIS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIBODY FORMATION; APOPTOSIS; B-LYMPHOCYTES; CELL DIVISION; CELL SURVIVAL; GENE DELETION; HUMANS; LYMPHOPOIESIS; MEMBRANE MICRODOMAINS; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 0036884819     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri955     Document Type: Review

References (154)

1. Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K. A B-cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ-chain gene. Nature 350, 423-426 (1991).
2. Lam, K. P., Kuhn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-1083 (1997). This paper shows the requirement for surface B-cell receptor (BCR) for the maintenance of mature B-cell subsets.
3. Meffre, E. & Nussenzweig, M. C. Deletion of immunoglobulin-β in developing B cells leads to cell death. Proc. Natl Acad. Sci. USA 99, 11334-11339 (2002). This paper proposes a requirement for surface BCR and signalling for immature B-cell survival.
4. Hardy, R. R. & Hayakawa, K. B-cell development pathways. Annu. Rev. Immunol. 19, 595-621 (2001).
5. Kurosaki, T. Genetic analysis of B-cell antigen receptor signaling. Annu Rev. Immunol. 17, 555-592 (1999).
6. Lowell, C. A. & Soriano, P. Knockouts of Src-family kinases: stiff bones, wimpy T cells and bad memories. Genes Dev. 10, 1845-1857 (1996).
7. Texido, G. et al. The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation. Mol. Cell. Biol. 20, 1227-1233 (2000).
8. 2-terminal kinase 1, and p38 mitogen-activated protein kinase. J. Exp. Med. 188, 1297-1306 (1998).
9. 2- mobilization through distinct pathways. EMBO J. 13, 1341-1349 (1994).
10. Turner, M. et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298-302 (1995).
11. Turner, M. & Billadeau, D. D. VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nature Rev. Immunol. 2, 476-486 (2002).
12. Holsinger, L. Jr et al. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8, 563-572 (1998).
13. Tarakhovsky, A. et al. Defective antigen-receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374, 467-470 (1995).
14. Zhang, R., Alt, F. W., Davidson, L., Orkin, S. H. & Swat, W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the Vav protoonccgene. Nature 374, 470-473 (1995).
15. Doody, G. M. et al. Signal transduction through Vav-2 participates in humoral immune responses and B-cell maturation. Nature Immunol. 2, 542-547 (2001).
16. Tedford, K. et al. Compensation between Vav-1 and Vav-2 in B-cell development and antigen-receptor signaling. Nature Immunol. 2, 548-555 (2001).
17. Inabe, K. et al. Vav3 modulates B-cell receptor responses by regulating phosphoinositide 3-kinase activation. J. Exp Med. 195, 189-200 (2002).
18. Marshall, A. J., Niiro, H., Yun, T. J. & Clark, E. A. Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cγ pathway. Immunol. Rev. 176, 30-46 (2000).
19. Fu, C., Turck, C. W., Kurosaki, T. & Chan, A. C. BLNK: a central linker protein in B-cell activation. Immunity 9, 93-103 (1998).
20. Hashimoto, S. et al. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK - functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood 94, 2357-2364 (1999).
21. Ishiai, M. et al. BLNK required for coupling Syk to PLCγ2 and Racl-JNK in B cells. Immunity 10, 117-125 (1999).
22. Pappu, R. et al. Requirement for B-cell linker protein (BLNK) in B-cell development. Science 286, 1949-1954 (1999).
23. Xu, S. et al. B-cell development and activation defects resulting in Xid-like immunodeficiency in BLNK/SLP-65-deficient mice. Int. Immunol. 12, 397-404 (2000).
24. Hayashi, K. et al. The B-cell-restricted adaptor BASH is required for normal development and antigen-receptor-mediated activation of B cells. Proc. Natl Acad. Sci. USA 97, 2755-2760 (2000).
25. Hashimoto, A. et al. Cutting edge: essential role of phospholipase Cγ2 in B-cell development and function. J. Immunol. 165, 1738-1742 (2000).
26. Wang, D. et al. Phospholipase Cγ2 is essential in the functions of B-cell and several Fc receptors. Immunity 13, 25-35 (2000).
27. Okada, T, Maeda, A., Iwamatsu, A., Gotoh, K. & Kurosaki, T. BCAP: the tyrosine kinase substrate that connects B-cell receptor to phosphoinositide 3-kinase activation. Immunity 13, 817-827 (2000).
28. Marshall, A. J. et al. A novel B-lymphocyte-associated adaptor protein, Bam32, regulates antigen-receptor signaling downstream of phosphatidylinositol 3-kinase. J. Exp. Med. 191, 1319-1332 (2000)
29. Niiro, H., Maeda, A., Kurosaki, T. & Clark, E. A. The B-lymphocyte adaptor molecule of 32 kD (Bam32) regulates B-cell antigen receptor signaling and cell survival. J. Exp. Med. 195, 143-149 (2002). References 28 and 29 show that after BCR ligation, BAM32 is recruited to the plasma membrane through its pleckstrin-homology domain, and that it binds and regulates the activation of PLC-2.
30. Shlapatska, L. M. et al. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J. Immunol. 166, 5480-5487 (2001).
31. Yankee, T. M., Solow, S. A., Draves, K. E. & Clark, E. A. Expression of the GrpL/Gads adaptor protein in B-cell subsets enhances BCR signaling through MAPK pathways. J. Immunol. (in the press).
32. Tuveson, D. A., Carter R. H., Soltoff, S. P. & Fearon, D. T. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260, 986-989 (1993).
33. Chacko, G. W. et al. Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP. J. Immunol. 157, 2234-2238 (1996).
34. Cyster, J. G. & Goodnow, C. C. Protein tyrosine phosphatase 1C negatively regulates antigen-receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2, 13-24 (1995).
35. Poe, J. C., Fujimoto, M., Jansen, P. J., Miller, A. S. & Tedder, T. F. CD22 forms a quaternary complex with SHIP Grb2 and Shc. A pathway for regulation of B-lymphocyte antigen receptor-induced calcium flux. J. Biol. Chem 275, 17420-17427 (2000).
36. Otipoby, K. L., Draves, K. E. & Clark, E. A. CD22 regulates B-cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1. J. Biol. Chem. 276, 44315-44322 (2001).
37. Schamel, W. W. & Reth, M. Monomeric and oligomeric complexes of the B-cell antigen receptor. Immunity 13, 5-14 (2000).
38. Pierce, S. K. Lipid rafts and B-cell activation. Nature Rev. Immunol. 2, 96-105 (2002).
39. Guo, B., Kato, R. M., Garcia-Lloret, M., Wahl, M. L. & Rawlings, D. J. Engagement of the human pre-B-cell receptor generates a lipid raft-dependent calcium signaling complex. Immunity 13, 243-253 (2000).
40. Bannish, G., Fuentes-Panana, E. M., Cambier, J. C., Pear, W. S. & Monroe, J. G. Ligand-independent signaling functions for the B-lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J. Exp. Med. 194, 1583-1596 (2001). This paper shows that the plasma-membrane localization of immunoglobulin-associated protein-α (Igα) and Igβ cytoplasmic domains provides basal signalling that is sufficient for transition from the pro-B-cell to pre-B-cell stage, which indicates a role for antigen-independent BCR in B-cell development.
41. Xavier, R., Brennan, T., Li, Q., McCormack, C. & Seed, B. Membrane compartmentation is required for efficient T-cell activation. Immunity 8, 723-732 (1998).
42. Fruman, D. A., Satterthwaite, A. B. & Witte, O. N. Xid-like phenotypes: a B-cell signalosome takes shape. Immunity 13, 1-3 (2000).
43. Reth, M. Oligomeric antigen receptors: a new view on signaling for the selection of lymphocytes. Trends Immunol. 22, 356-360 (2001). Together with reference 37, this paper proposes an intriguing model in which in the absence of antigen ligation, oligomeric BCR complexes are formed and transduce basal BCR signalling.
44. 2+ flux. Curr. Biol. 10, 393-396 (2000).
45. Petrie, R. J., Schnetkamp, P. P., Patel, K. D., Awasthi-Kalia, M. & Deans, J. P. Transient translocation of the B-cell receptor and Src homology 2 domain-containing inositol phosphatase to lipid rafts: evidence toward a role in calcium regulation. J. Immunol. 165, 1220-1227 (2000).
46. Braun, J., Hochman, P. S. & Unanue, E. R. Ligand-induced association of surface immunoglobulin with the detergent-insoluble cytoskeletal matrix of the B lymphocyte. J. Immunol. 128, 1198-1204 (1982).
47. Pure, E. & Tardelli, L. Tyrosine phosphorylation is required for ligand-induced internalization of the antigen receptor on B lymphocytes. Proc. Natl Acad. Sci. USA 89.114-117 (1992).
48. Ma, H. et al. Visualization of Syk-antigen-receptor interactions using green fluorescent protein: differential roles for Syk and Lyn in the regulation of receptor capping and internalization. J. Immunol. 166, 1507-1516 (2001).
49. Fruman, D. A. et al. Impaired B-cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283, 393-397 (1999).
50. Pogue, S. L., Kurosaki, T., Bolen, J. & Herbst, R. B-cell antigen receptor-induced activation of Akt promotes B-cell survival and is dependent on Syk kinase. J. Immunol. 165, 1300-1306 (2000).
51. Okkenhaug, K. et al. Impaired B- and T-cell antigen receptor signaling in p110δ PI 3-kinase mutant mice. Science 297, 1031-1034 (2002).
52. Clayton, E. et al. A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B-cell development and activation. J. Exp. Med. 196, 753-763 (2002).
53. Datta, S. R. et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241 (1997).
54. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. & Hemmings, B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 (1995).
55. Craxton, A., Jiang, A., Kurosaki, T. & Clark, E. A. Syk and Bruton's tyrosine kinase are required for B-cell antigen receptor-mediated activation of the kinase Akt. J. Biol. Chem. 274, 30644-30650 (1999).
56. Gold, M. R. et al. The B-cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J Immunol. 163, 1894-1905 (1999).
57. Sears, R. C. & Nevins, J. R. Signaling networks that link cell proliferation and cell fate. J Biol. Chem. 277, 11617-11620 (2002).
58. Hashimoto, A. et al. Involvement of guanosine triphosphatases and phospholipase C-y2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B-cell antigen receptor. J. Exp. Med. 188, 1287-1295 (1998).
59. Ballif, B. A. & Blenis, J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell-survival signals. Cell Growth Differ. 12, 397-408 (2001).
60. Richards, J. D., Dave, S. H., Chou, C. H., Mamchak, A. A. & DeFranco, A. L. Inhibition of the MEK/ERK signaling pathway blocks a subset of B-cell responses to antigen. J. Immunol. 166, 3855-3864 (2001).
61. Piatelli, M. J., Doughty, C. & Chiles, T. C. Requirement for HSP90 chaperone-dependent MEK1/2-ERK pathway for B-cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes. J. Biol. Chem. 277, 12144-12150 (2002). References 60 and 61 show that the RAF-MEK-ERK pathway has a crucial role in BCR-induced proliferation of mature B cells.
62. Huser, M. et al. MEK kinase activity is not necessary for Raf-1 function. EMBO J. 20, 1940-1951 (2001).
63. Mikula, M. et al. Embryonic lethality and fetal-liver apoptosis in mice lacking the c-raf-1 gene. EMBO J. 20, 1952-1962 (2001).
64. Wang, H. G., Rapp, U. R. & Reed, J. C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87, 629-638 (1996).
65. Barkett, M. & Gilmore, T. D. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18, 6910-6924 (1999).
66. Kaisho, T. et al. IκB kinase-α is essential for mature B-cell development and function. J. Exp. Med. 193, 417-426 (2001).
67. Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495-1499 (2001).
68. Pasparakis, M., Schmidt-Supprian, M. & Raiewsky, K. IκB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196, 743-752 (2002). This paper shows that IKK-mediated NF-κB activation is crucial for the maintenance of mature B-cell subsets.
69. Petro, J. B. & Khan, W. N. Phospholipase C-y2 couples Bruton's tyrosine kinase to the NF-κB signaling pathway in B lymphocytes. J. Biol. Chem. 276, 1715-1719 (2001).
70. Petro, J. B., Rahman, S. M., Ballard, D W & Khan, W. N. Bruton's tyrosine kinase is required for activation of IκB kinase and nuclear factor-κB in response to B-cell receptor engagement. J Exp. Med 191, 1745-1754 (2000).
71. Tan, J. E., Wong, S. C., Gan, S. K., Xu, S. & Lam, K. P. The adaptor protein BLNK is required for B-cell antigen receptor-induced activation of nuclear factor-κB and cell-cycle entry and survival of B lymphocytes. J. Biol. Chem. 276, 20055-20063 (2001).
72. Parekh, D. B., Ziegler, W. & Parker, P. J. Multiple pathways control protein kinase C phosphorylation. EMBO J. 19, 496-503 (2000).
73. Lin, X., O'Mahony, A., Mu, Y., Geleziunas, R. & Greene, W. C. Protein kinase Cθ participates in NF-κB activation induced by CD3-CD28 costimulation through selective activation of IκB kinase-β. Mol. Cell. Biol. 20, 2933-2940 (2000).
74. Mecklenbrauker, I., Saijo, K., Zheng, N. Y., Leitges, M. & Tarakhovsky, A. Protein kinase Cδ controls self-antigen-induced B-cell tolerance. Nature 416, 860-865 (2002).
75. Miyamoto, A. et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ. Nature 416, 865-869 (2002).
76. Saijo, K. et al. Protein kinase Cβ controls nuclear factor-κB activation in B cells through selective regulation of the IκB kinase-α. J. Exp. Med. 195, 1647-1652 (2002).
77. Su, T. T. et al. PKC-β controls IκB kinase lipid-raft recruitment and activation in response to BCR signaling. Nature Immunol. 3, 780-786 (2002). References 76 and 77 show the importance of PKCβ for BCR-induced NF-κB activation, and reference 77 also shows that BTK and PKCβ have distinct roles in the maturation of follicular B cells.
78. Baldwin, A. S. Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683 (1996).
79. Grumont, R. J. & Gerondakis, S. The subunit composition of NF-κB complexes changes during B-cell development. Cell. Growth Differ. 5, 1321-1331 (1994).
80. Anderson, J. S., Teutsch, M., Dong, Z. & Wortis, H. H. An essential role for Bruton's tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl Acad. Sci USA 93, 10966-10971 (1996).
81. Grumont, R. J. et al. B lymphocytes differentially use the Rel and nuclear factor-κB1 (NF-κB1) transcription factors to regulate cell-cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187, 663-674 (1998).
82. Grumont, R. J., Rourke, I. J. & Gerondakis, S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13, 400-411 (1999).
83. 2- homeostasis by altering expression of inositol 1,4,5-trisphosphate receptors. Proc. Natl Acad. Sci. USA 99, 9830-9835 (2002).
84. Joyce, D. et al. NF-κB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev. 12, 73-90 (2001).
85. Glassford, J. et al. Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen receptor. J. Biol. Chem. 276, 41040-41048 (2001).
86. Aagaard-Tillery, K. M. & Jelinek, D. F. Differential activation of a calcium-dependent endonuclease in human B lymphocytes. Role in lonomycin-induced apoptosis. J. Immunol. 155, 3297-3307 (1995).
87. Sugawara, H., Kurosaki, M., Takata, M. & Kurosaki, T. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J. 16, 3078-3088 (1997).
88. 1 and JNK2 have similar and stage-dependent roles in regulating T-cell apoptosis and proliferation. J. Exp. Med. 193, 317-328 (2001).
89. Berard, M. et al. Mitochondria connects the antigen receptor to effector caspases during B-cell receptor-induced apoptosis in normal human B cells. J. Immunol. 163, 4655-4662 (1999).
90. Bouchon, A., Krammer, P. H. & Walczak, H. Critical role for mitochondna in B-cell receptor-mediated apoptosis. Eur. J. Immunol. 30, 69-77 (2000).
91. Herold, M. J., Kuss, A. W., Kraus, C. & Berberich, I. Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cells. J. Immunol. 168, 3902-3909 (2002).
92. Sandel, P. C. & Monroe, J. G. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity 10, 289-299 (1999).
93. Loder, F. et al. B-cell development in the spleen takes place in discrete steps and is determined by the quality of B-cell receptor-derived signals. J. Exp. Med. 190, 75-89 (1999). The authors characterize T1 and T2 cells in the spleen, and also show that the strength of BCR signalling affects the generation of transitional and follicular B cells.
94. Carsetti, R., Kohler, G. & Lamers, M. C. Transitional B cells are the target of negative selection in the B-cell compartment. J. Exp. Med. 181, 2129-2140 (1995).
95. Su, T. T. & Rawlings, D. J. Transitional B-lymphocyte subsets operate as distinct checkpoints in murine splenic B-cell development. J. Immunol. 168, 2101-2110 (2002). This paper shows that there are distinct profiles of BCR-induced signalling in transitional and follicular B cells.
96. Allman, D. et al. Resolution of three nonproliferative immature splenic B-cell subsets reveals multiple selection points during peripheral B-cell maturation. J. Immunol 167, 6834-6840 (2001).
97. Chung, J. B., Sater, R. A., Fields, M. L., Erikson, J. & Monroe, J. G. CD23 defines two distinct subsets of immature B cells which differ in their responses to T-cell help signals. Int. Immunol. 14, 157-166 (2002).
98. Garside, P. et al. Visualization of specific B- and T-lymphocyte interactions in the lymph node. Science 281, 96-99 (1998).
99. Torres, R. M., Flaswinkel, H., Reth, M. & Rajewsky, K. Aberrant B-cell development and immune response in mice with a compromised BCR complex. Science 272, 1802-1804 (1996).
100. Reichlin, A. et al. B-cell development is arrested at the immature B-cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin-β. J. Exp. Med. 193, 13-23 (2001).
101. Turner, M. et al. Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B-cell pool. J. Exp. Med. 186, 2013-2021 (1997).
102. Cornall, R. J., Cheng, A. M. Pawson, T. & Goodnow, C. C. Role of Syk in B-cell development and antigen-receptor signaling. Proc. Natl Acad. Sci USA 97, 1713-1718 (2000).
103. Batten, M. et al. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192, 1453-1466 (2000).
104. Schiemann, B. et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111-2114 (2001). This paper shows a crucial role for BAFF in transition from the T1 to T2 stage, and also shows that Baff-deficient mice have a similar phenotype to A/WySnJ mice, which have a mutation of the Baff receptor.
105. Moore, P. A. et al. BLyS: member of the tumor-necrosis factor family and B-lymphocyte stimulator. Science 285, 260-263 (1999).
106. Schneider, P. et al. BAFF, a novel ligand of the tumor-necrosis factor family, stimulates B-cell growth. J. Exp. Med. 189, 1747-1756 (1999).
107. Hsu, B. L., Harless, S. M., Lindsley, R. C., Hilbert, D. M. & Cancro, M. P. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J. Immunol. 168, 5993-5996 (2002).
108. Do, R. K. et al. Attenuation of apoptosis underlies B-lymphocyte stimulator enhancement of humoral immune response. J. Exp Med. 192, 953-964 (2000).
109. Claudio, E., Brown, K., Park, S., Wang, H. & Siebenlist, U. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nature Immunol. 3, 958-965 (2002).
110. Kayagaki, N. et al. BAFF/BLyS receptor 3 binds the B-cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2. Immunity 17, 515-524 (2002). References 109 and 110 show that BAFF signalling involves a non-classical NF-κB pathway (NEMO-independent processing of NF-κB2) and that this requires the BAFF receptor.
111. Marsters, S. A. et al. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr. Biol. 10, 785-788 (2000).
112. Franzoso, G. et al. Requirement for NF-κK in osteoclast and B-cell development. Genes Dev. 11, 3482-3496 (1997).
113. Berland, R. & Wortis, H. H. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20, 253-300 (2002).
114. Martin, F. & Kearney, J. F. Marginal-zone B cells. Nature Rev. Immunol. 2, 323-335 (2002).
115. Chan, V. W., Meng, F., Soriano, P., DeFranco, A. L. & Lowell, C. A. Characterization of the B-lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7, 69-81 (1997).
116. Meade, J., Fernandez, C. & Turner, M. The tyrosine kinase Lyn is required for B-cell development beyond the T1 stage in the spleen: rescue by over-expression of Bcl-2. Eur. J. Immunol. 32, 1029-1034 (2002).
117. Ellmeier, W. et al. Severe B-cell deficiency in mice lacking the Tec-kinase family members Tec and Btk. J. Exp. Med. 192, 1611-1624 (2000).
118. Martin, F. & Kearney, J. F. Positive selection from newly formed to marginal-zone B cells depends on the rate of clonal production, CD19 and Btk. Immunity 12, 39-49 (2000). This paper shows that CD19 and BTK have distinct roles in the development of marginal-zone (MZ) and follicular B cells.
119. Cariappa, A. et al. The follicular versus marginal-zone B-lymphocyte cell-fate decision is regulated by Aiolos, Btk and CD21. Immunity 14, 603-615 (2001). This paper indicates that a strong BCR signal might favour the generation of follicular B cells, whereas a weak BCR signal favours the generation of MZ B cells.
120. Suzuki, H. et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 283, 390-392 (1999).
121. Yamazaki, T. et al. Essential immunoregulatory role for BCAP in B-cell development and function. J. Exp. Med. 195, 535-545 (2002).
122. Rolink, A. G., Tschopp, J., Schneider, P. & Melchers, F. BAFF is a survival and maturation factor for mouse B cells. Eur. J. Immunol. 32, 2004-2010 (2002).
123. Hayakawa, K. et al. Positive selection of natural autoreactive B cells. Science 285, 113-116 (1999).
124. Hao, Z. & Rajewsky, K. Homeostasis of peripheral B cells in the absence of B-cell influx from the bone marrow. J Exp Med. 194, 1151-1164 (2001). This paper shows that blockade of the entry of immature B cells from the bone marrow leads to a gradual decrease in the number of follicular B cells, whereas the levels of MZ and peritoneal B cells remain unchanged in this setting.
125. Balazs, M., Martin, F., Zhou, T. & Kearney, J. Blood dendritic cells interact with splenic marginal-zone B cells to initiate T-independent immune responses. Immunity 17, 341 (2002).
126. Rothstein, T. L. Cutting edge commentary: two B-1 or not to be one. J. Immunol. 168, 4257-4261 (2002).
127. + peritoneal B cells, and show that it is similar to that of anergic B cells.
128. Leitges, M. et al. Immunodeficiency in protein kinase Cβ-deficient mice. Science 273, 788-791 (1996).
129. Croker, B. A. et al. The Rac2 guanosine triphosphatase regulates B-lymphocyte antigen-receptor responses and chemotaxis and is required for establishment of B-1 a and marginal-zone B lymphocytes. J Immunol. 168, 3376-3386 (2002).
130. Engel, P. et al. Abnormal B-lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal-transduction molecule. Immunity 3, 39-50 (1995)
131. Rickert, R. C., Rajewsky, K. & Roes, J. Impairment of T-cell-dependent B-cell responses and B-1-cell development in CD19-deficient mice. Nature 376, 352-355 (1995).
132. Sato, S. et al. CD22 is both a positive and negative regulator of B-lymphocyte antigen-receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5, 551-562 (1996).
133. -/- mice. Nature Immunol. 3, 542-548 (2002).
134. Morgan, B. et al. Aiolos, a lymphoid-restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16, 2004-2013 (1997).
135. Wang, J H. et al. Aiolos regulates B-cell activation and maturation to effector state. Immunity 9, 543-553 (1998).
136. Samardzic, T. et al. Reduction of marginal-zone B cells in CD22-deficient mice. Eur. J. Immunol. 32. 561-567 (2002).
137. Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J. V. Absence of marginal-zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nature Immunol. 1, 31-36 (2000).
138. Ganiu, R. K. et al. The α-chemokine, stromal-cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal-transduction pathways. J. Biol. Chem. 273, 23169-23175 (1998).
139. Cariappa, A., Liou, H. C., Horwitz, B. H. & Pillai, S. Nuclear factor-κB is required for the development of marginal-zone B lymphocytes. J. Exp. Med. 192, 1175-1182 (2000). This paper shows that NF-κB is more crucial for the development of MZ B cells than of follicular B cells.
140. Laudanna, C., Kim, J. Y., Constantin. G. & Butcher, E. C. Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 186, 37-46 (2002).
141. 1 integrin, which are required for MZ B-cell localization.
142. Bureau, F. et al. Constitutive nuclear factor-κB activity preserves homeostasis of quiescent mature lymphocytes and granulocytes by controlling the expression of distinct Bcl-2-family proteins. Blood 99, 3683-3691 (2002).
143. Xu, S. & Lam. K. P. Delayed cellular maturation and decreased immunoglobulin-κ light chain production in immature B lymphocytes lacking B-cell linker protein. J. Exp. Med. 196, 197-206 (2002).
144. Chung, J. B., Beumeister, M. A. & Monroe, J. G. Cutting edge: differential sequestration of plasma-membrane-associated B-cell antigen receptor in mature and immature B cells into glycosphingolipid-enriched domains. J. Immunol. 166. 736-740 (2001).
145. Sproul, T. W., Malapati, S., Kim, J. & Pierce, S. K. Cutting edge: B-cell antigen receptor signaling occurs outside lipid rafts in immature B cells. J. Immunol. 165, 6020-6023 (2000).
146. Merino, R., Ding, L., Veis, D. J., Korsmeyer, S. J. & Nunez, G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 13, 683-691 (1994).
147. Tomayko, M. M. & Cancro, M. P. Long-lived B cells are distinguished by elevated expression of A1. J. Immunol. 160, 107-111 (1998).
148. Nakayama, K. et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261, 1584-1588 (1993).
149. Otero, D. C., Omon, S. A. & Rickert, R. C. CD19-dependent activation of Akt kinase in B lymphocytes. J. Biol. Chem, 276, 1474-1478 (2001).
150. Otipoby, K. L. et al. CD22 regulates thymus-independent responses and the Iifespan of B cells. Nature 384, 634-637 (1996).
151. King, L. B., Norvell, A. & Monroe, J. G. Antigen-receptor-induced signal-transduction imbalances associated with the negative selection of immature B cells. J. Immunol. 162, 2655-2662 (1999).
152. Yellen, A. J., Glenn, W., Sukhatme, V. P. Cao, X. M. & Monroe, J. G. Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice. J. Immunol. 146, 1446-1454 (1991).
153. -/- mice. J. Exp. Med. 191, 781-794 (2000).
154. Koncz, G., Bodor, C., Kovesdi, D., Gati, R. & Sarmay, G. BCR-mediated signal transduction in immature and mature B cells Immunol. Lett. 82, 41-49 (2002).